Interaction between tadalafil and itraconazole [4]

Annals of Pharmacotherapy

Volumn 39, Issue 1, 2005, Pages 200-

  Galatti, Laura ^a   Fioravanti, Antonio ^b   Salvo, Francesco ^c   Polimeni, Giovanni ^c   Giustini, Saffi E ^d  

^a UNIVERSITY OF MESSINA   (Italy)

^b Fano Asur ^*  (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d Italian College of General Practitioners   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE; SILDENAFIL; TADALAFIL;

ADULT; CASE REPORT; DRUG EFFICACY; DRUG SAFETY; DRUG USE; ERECTILE DYSFUNCTION; HUMAN; LETTER; MALE; MICTURITION; ONYCHOMYCOSIS; PRESCRIPTION; PRIAPISM; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CARBOLINES; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; HUMANS; ITRACONAZOLE; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PRIAPISM;

EID: 11144228717     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E383     Document Type: Letter

References (5)

1. Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequence. BJU Int 1999;84:50-6.
2. Sur RL, Kane CJ. Sildenafil citrate-associated priapism. Urology 2000;55:950.
3. Product information. Cialis (tadalafil). Sesto Fiorentino (FI), Italy: Eli Lilly, January 2004.
4. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
5. Warrington JS, Shader RI, Von Moltke LL, Greenblatt DJ. In vitro biotransformation of sildenafil (Viagra): identification of human cytochromes and potential drug interactions. Drug Metab Dispos 2000;28:392-7.